Kidney transplant drug halves the early risk of rejection and allows less toxic treatment

(University of Oxford) Oxford University scientists have shown that a powerful drug given at the time of a kidney transplant operation not only halves the early risk of rejection, but that it also allows a less toxic regimen of anti-rejection drugs to be used after the operation.